1
|
Alonso-Diez A, Affolter V, Sevane N, Dunner S, Valdivia G, Clemente M, De Andrés P, Illera J, Pérez-Alenza M, Peña L. Cell adhesion molecules E-cadherin and CADM1 are differently expressed in canine inflammatory mammary cancer. Res Vet Sci 2022; 152:307-313. [DOI: 10.1016/j.rvsc.2022.08.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2021] [Revised: 07/27/2022] [Accepted: 08/23/2022] [Indexed: 10/14/2022]
|
2
|
Valdivia G, Alonso-Diez A, Suarez M, García P, Alonso-Miguel D, Affolter V, LaDouceur E, Perez-Alenza M, Peña L. First Description of Canine Benign Mammary Lymph Node Inclusions: A Diagnostic Challenge for Pathologists. J Comp Pathol 2022. [DOI: 10.1016/j.jcpa.2021.11.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
3
|
Valdivia G, Alonso-Miguel D, Alonso-Diez A, Beiss V, Fiering S, Steinmetz N, Perez-Alenza M, Arias-Pulido H, Peña L. ECPMV Neoadjuvant Immunotherapy Induced Neutrophilic Infiltration and Increased Survival in Canine Inflammatory Mammary Cancer. J Comp Pathol 2022. [DOI: 10.1016/j.jcpa.2021.11.053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
4
|
Valdivia G, Schmidt A, Schmidt B, Rivera F, Oñate A, Navarrete C, Campos J, Labarca G. Association between cardiovascular mortality and STOP-Bang questionnaire scores in a cohort of hospitalized patients: a prospective study. J Bras Pneumol 2021; 47:e20210039. [PMID: 34495174 PMCID: PMC8979666 DOI: 10.36416/1806-3756/e20210039] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2021] [Accepted: 06/09/2021] [Indexed: 01/10/2023] Open
Abstract
OBJECTIVE Obstructive sleep apnea (OSA) is associated with an increased risk of mortality and cardiometabolic diseases. The STOP-Bang questionnaire is a tool to screen populations at risk of OSA and prioritize complementary studies. Our objective was to evaluate the clinical utility of this questionnaire in identifying patients at an increased risk of mortality after discharge in a cohort of hospitalized patients. METHODS This was a prospective cohort study involving consecutive patients admitted to an internal medicine unit between May and June of 2017 who were reevaluated three years after discharge. At baseline, we collected data on comorbidities (hypertension, obesity, diabetes, and fasting lipid profile) and calculated STOP-Bang scores, defining the risk of OSA (0-2 score, no risk; ≥ 3 score, risk of OSA; and ≥ 5 score, risk of moderate-to-severe OSA), which determined the study groups. We also recorded data regarding all-cause and cardiovascular mortality at the end of the follow-up period. RESULTS The sample comprised 435 patients. Of those, 352 (80.9%) and 182 (41.8%) had STOP-Bang scores ≥ 3 and ≥ 5, respectively. When compared with the group with STOP-Bang scores of 0-2, the two groups showed higher prevalences of obesity, hypertension, diabetes, and dyslipidemia. Multivariate analysis showed an independent association between cardiovascular mortality and STOP-Bang score ≥ 5 (adjusted hazard ratio = 3.12 [95% CI, 1.39-7.03]; p = 0.01). Additionally, previous coronary heart disease was also associated with cardiovascular mortality. CONCLUSIONS In this cohort of hospitalized patients, STOP-Bang scores ≥ 5 were able to identify patients at an increased risk of cardiovascular mortality three years after discharge.
Collapse
Affiliation(s)
- Gabriel Valdivia
- . Facultad de Medicina, Universidad de Concepción, Los Ángeles, Chile
| | - Alexia Schmidt
- . Facultad de Medicina, Universidad de Concepción, Los Ángeles, Chile
| | - Bettina Schmidt
- . Facultad de Medicina, Universidad de Concepción, Los Ángeles, Chile
| | - Francisca Rivera
- . Facultad de Medicina, Universidad de Concepción, Los Ángeles, Chile
| | - Aileen Oñate
- . Facultad de Medicina, Universidad San Sebastian, Los Ángeles, Chile
| | - Camila Navarrete
- . Facultad de Medicina, Universidad San Sebastian, Los Ángeles, Chile
| | - Josue Campos
- . Facultad de Medicina, Universidad de Concepción, Los Ángeles, Chile
| | - Gonzalo Labarca
- . Facultad de Medicina, Universidad de Concepción, Los Ángeles, Chile.,. Division of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston (MA) USA
| |
Collapse
|
5
|
Valdivia G, Navarrete C, Oñate A, Schmidt B, Fuentes R, Espejo E, Enos D, Fernandez-Bussy I, Labarca G. [Association between high vitamin B12 levels and one year mortality in older people admitted to the hospital]. Rev Med Chil 2020; 148:46-53. [PMID: 32730435 DOI: 10.4067/s0034-98872020000100046] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2019] [Accepted: 12/18/2019] [Indexed: 11/17/2022]
Abstract
BACKGROUND Supplementation of vitamin B12 in older adults is a common practice to avoid vitamin B12 insufficiency. However, there is a paucity of information about the effects of cobalamin excess. AIM To asses any potential effects of high levels vitamin B12 on mortality on adults aged ≥ 65 years admitted to an internal medicine service. MATERIAL AND METHODS We Prospectively studied patients admitted to an internal medicine service of an academic hospital from September 2017 to September 2018, who were able to give their consent and answer questionnaires. We tabulated age, gender, medical history, comorbidity index (Charlson), frailty score (Fried scale), admission diagnosis and blood tests performed within 48 hours of admission. The primary outcome was death by any cause in less of 30 days or after one of year follow up, determined according to death certificates. RESULTS We included 93 patients aged 65 to 94 years (53% males). Fifteen patients died during the year of follow up (five within 30 days of admission). Those who died had higher cobalamin levels than survivors (1080.07 ± 788.09 and 656.68 ± 497.33 pg/mL respectively, p = 0.02). Patients who died had also a significantly lower corrected serum calcium, sodium (p = 0.04) and a medical history of chronic liver disease (p = 0.03). In the multivariable analysis, only vitamin B12 preserved the association with mortality (p = 0.009). CONCLUSIONS There was a significant association between high levels of cobalamin and all-cause mortality in this group of patients aged ≥ 65 years-old.
Collapse
Affiliation(s)
- Gabriel Valdivia
- Facultad de Medicina, Universidad de Concepción, Concepción, Chile
| | - Camila Navarrete
- Facultad de Medicina, Universidad San Sebastián, Concepción, Chile
| | - Aileen Oñate
- Facultad de Medicina, Universidad San Sebastián, Concepción, Chile
| | - Bettina Schmidt
- Facultad de Medicina, Universidad San Sebastián, Concepción, Chile
| | - Ricardo Fuentes
- Facultad de Medicina, Universidad San Sebastián, Concepción, Chile
| | | | | | | | - Gonzalo Labarca
- Facultad de Medicina, Universidad de Concepción, Concepción, Chile
| |
Collapse
|
6
|
Valdivia G, Alonso A, Alonso D, Suárez M, García P, Ortiz-Díez G, Pérez-Alenza D, Peña L. Canine Mammary Epitheliosis: The Hidden Threat. J Comp Pathol 2020. [DOI: 10.1016/j.jcpa.2019.10.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
7
|
Smith SJ, Valdivia G. Misbehaving twins: how messy is too messy. Acta Crystallogr A Found Adv 2019. [DOI: 10.1107/s0108767319096661] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
8
|
Labarca G, Valdivia G, Oñate A, Navarrete C, Araya J, Fernandez-Bussy I, Dreyse J, Jorquera J. Prevalence of STOP BANG questionnaire and association with major cardiovascular events in hospitalized population: is it enough with currently used cardiovascular risk measurements? Sleep Med 2019; 61:82-87. [PMID: 31416696 DOI: 10.1016/j.sleep.2019.02.019] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/09/2019] [Revised: 01/31/2019] [Accepted: 02/26/2019] [Indexed: 11/28/2022]
Abstract
Cardiovascular risk (CR) is associated with obstructive sleep apnea hypopnea syndrome (OSAHS). This association enhances the risk of major adverse cardiovascular events (MACE); nevertheless, data from hospitalized populations and interactions among these conditions remain unclear. PURPOSE To evaluate the risk of MACE in the population with risk of OSAHS using the STOP-BANG questionnaire. METHODS We performed a prospective study in an academic hospital from 2017 to 2018. Data included demography, admissions, STOP-BANG score and CR using AHA scores. The primary outcome was risk of MACE in participants with low risk of OSAHS (STOP-BANG 0-2 points), risk of OSAHS (≥3 points) and risk of moderate/severe OSAHS (≥5 points). Risk of MACE was evaluated using odds ratios (OR), and average CR was evaluated using the t-test. RESULTS A total of 441 participants were included. The cumulative prevalence of STOP BANG ≥3 points was 80.9%, and that of ≥5 points was 41.6%. OR of MACE ≥3 points was 3.93 (CI 2.08-7.24) (p < 0.001) compared with <3 points, and Average CR was 10.91% (SD ± 2.13) at <3 points versus 24.3% (SD ± 1.24) for ≥3 points for ≥5 points OR of MACE was 1.72 (CI 1.18-2.59) (p = 0.005) and average CR was 26.14% (SD ± 1.63). However, after multivariable analysis, gender differences and previous heart failure were independently associated to MACE. CONCLUSION The risk of OSAHS in the hospitalized population is high. This population has a higher risk of MACE and higher CRs than do low-risk participants. Conversely, gender and heart failure are potential cofounders.
Collapse
Affiliation(s)
- Gonzalo Labarca
- Facultad de Medicina, Universidad San Sebastian, Concepcion, Chile; Complejo Asistencial Dr. Victor Rios Ruiz, Los Angeles, Chile.
| | - Gabriel Valdivia
- Facultad de Medicina, Universidad de Concepcion, Los Angeles, Chile
| | - Aileen Oñate
- Facultad de Medicina, Universidad San Sebastian, Concepcion, Chile
| | - Camila Navarrete
- Facultad de Medicina, Universidad San Sebastian, Concepcion, Chile
| | - Jose Araya
- Facultad de Medicina, Universidad San Sebastian, Concepcion, Chile
| | | | - Jorge Dreyse
- Centro de Enfermedades Respiratorias, Clinica Las Condes, Santiago, Chile
| | - Jorge Jorquera
- Centro de Enfermedades Respiratorias, Clinica Las Condes, Santiago, Chile
| |
Collapse
|
9
|
Mayordomo JI, Andres R, Isla MD, Murillo L, Cajal R, Yubero A, Blasco C, Lasierra P, Palomera L, Fuertes MA, Güemes A, Sousa R, Garcia-Prats MD, Escudero P, Saenz A, Godino J, Marco I, Saez B, Visus C, Asin L, Valdivia G, Larrad L, Tres A. Results of a Pilot Trial of Immunotherapy with Dendritic Cells Pulsed with Autologous Tumor Lysates in Patients with Advanced Cancer. Tumori 2018; 93:26-30. [PMID: 17455868 DOI: 10.1177/030089160709300106] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Aims and background The purpose of the study was to test the immunological and clinical effects of infusions of dendritic cells pulsed with autologous tumor lysate in patients with advanced cancer. Patients and methods Peripheral blood mononuclear cells from 15 patients with metastatic cancer (melanoma in 10, lung cancer in 2, renal cell carcinoma in 1, sarcoma in 1, breast cancer in 1) were harvested by leukapheresis after mobilization with GM-CSF (5 μg/kg/day s.c. for 4 days). Mononuclear cells were separated and cultured in GM-CSF (1000 U/ml) and interleukin-4 (1000 U/ml) for 7 days. Phenotype was assessed by 2-color flow cytometry and immunocytochemistry. On day 6, dendritic cells were pulsed with 1 g of fresh autologous tumor lysate for 24 h and infused intravenously. Interleukin-2 (6 million IU), interferon a (4 million IU) and GM-CSF (400 μg) were injected s.c. daily for 10 days beginning on the day of dendritic cell infusion. Treatment was repeated every 21 days for 3 courses. Results The morphology, immunocytochemistry and phenotype of cultured cells was consistent with dendritic cells: intense positivity for HLA-DR and CD86, with negativity for markers of other lineages, including CD3, CD4, CD8 and CD14. More than 5 × 107 dendritic cells were injected in all patients. Nine patients developed >5 mm delayed type cutaneous hypersensitivity reactions to tumor lysate ± GM-CSF after the first immunization (larger than GM-CSF in all cases). Median delayed type cutaneous hypersensitivity to lysate + GM-CSF was 3 cm after the third immunization. One melanoma patient with skin, liver, lung and bone metastases had a partial response lasting 8 months (followed by progression in the brain). Seven patients had stable disease for >3 months, and 7 had progression. Conclusions Infusion of tumor lysate-pulsed dendritic cells induces a strong cell-mediated antitumor immune reaction in patients with advanced cancer and has some clinical activity.
Collapse
|
10
|
Calderón J, Flores P, Aguirre JM, Valdivia G, Padilla O, Barra I, Scoriels L, Herrera S, González A, Massardo L. Impact of cognitive impairment, depression, disease activity, and disease damage on quality of life in women with systemic lupus erythematosus. Scand J Rheumatol 2016; 46:273-280. [PMID: 27701937 DOI: 10.1080/03009742.2016.1206617] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
OBJECTIVES To define the relative role of cognitive impairment, depression, disease activity, and disease damage in the decreased health-related quality of life (HRQoL) frequently observed in systemic lupus erythematosus (SLE) patients. METHOD We studied 101 Chilean female SLE patients and applied the 12-item Medical Outcomes Study (MOS) Short Form Health Survey version 2 (SF-12v2) to assess HRQoL and the Cambridge Neuropsychological Test Automated Battery (CANTAB) to assess cognitive function. Analysis of covariance (ANCOVA) models included demographic and disease-related factors and cognitive function tests of sustained attention, memory, and executive function. RESULTS All measures of HRQoL were lower in the 101 female SLE patients compared to the women from the Chilean general population. HRQoL was associated with the following factors: (i) depression symptoms, which were detrimental to all components of the physical and mental HRQoL scores; (ii) executive dysfunction (spatial planning), which was associated with lower scores on role limitations due to physical health problems and emotional problems, and general health perceptions; (iii) higher activity and organ damage were deleterious to role physical, bodily pain, and physical summary scores; and (iv) higher damage also impacted physical function. Impairments in sustained attention and memory did not decrease the HRQoL. CONCLUSIONS Our results highlight the relevance of executive dysfunction to poor physical and mental health components of HRQoL in SLE together with depression, while disease activity and disease damage are associated with lower HRQoL physical components. The need for cognitive function evaluation and rehabilitation in SLE is indicated.
Collapse
Affiliation(s)
- J Calderón
- a Department of Psychiatry, Faculty of Medicine , Pontifical Catholic University of Chile , Santiago , Chile
| | - P Flores
- a Department of Psychiatry, Faculty of Medicine , Pontifical Catholic University of Chile , Santiago , Chile
| | - J M Aguirre
- a Department of Psychiatry, Faculty of Medicine , Pontifical Catholic University of Chile , Santiago , Chile
| | - G Valdivia
- b Department of Public Health, Faculty of Medicine , Pontifical Catholic University of Chile , Santiago , Chile
| | - O Padilla
- b Department of Public Health, Faculty of Medicine , Pontifical Catholic University of Chile , Santiago , Chile
| | - I Barra
- c School of Medicine, Faculty of Medicine , Pontifical Catholic University of Chile , Santiago , Chile
| | - L Scoriels
- d Institute of Biomedical Sciences , Federal University of Rio de Janeiro , Rio de Janeiro , Brazil
| | - S Herrera
- c School of Medicine, Faculty of Medicine , Pontifical Catholic University of Chile , Santiago , Chile
| | - A González
- e Department of Clinical Immunology and Rheumatology, Faculty of Medicine , Pontifical Catholic University of Chile , Santiago , Chile.,f Centre for Ageing and Regeneration (CARE), Department of Molecular and Cell Biology, Faculty of Biological Sciences , Pontifical Catholic University of Chile , Santiago , Chile
| | - L Massardo
- e Department of Clinical Immunology and Rheumatology, Faculty of Medicine , Pontifical Catholic University of Chile , Santiago , Chile
| |
Collapse
|
11
|
Montes de Oca M, Halbert RJ, Talamo C, Perez-Padilla R, Lopez MV, Muiño A, Jardim JRB, Valdivia G, Pertuzé J, Moreno D, Menezes AMB. Paid employment in subjects with and without chronic obstructive pulmonary disease in five Latin American cities: the PLATINO study. Int J Tuberc Lung Dis 2012; 15:1259-64, i-iii. [PMID: 21943855 DOI: 10.5588/ijtld.10.0508] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Chronic obstructive pulmonary disease (COPD) is a costly condition that frequently causes permanent work disabilities. Little information exists regarding the impact of COPD on work force participation and the indirect costs of the disease in developing countries. OBJECTIVE To examine the frequency of paid employment and factors influencing it in a Latin-American population-based study. METHODS Post-bronchodilator FEV(1)/FVC < 0.70 (forced expiratory volume in 1 s/forced vital capacity) was used to define COPD. Information regarding paid work was assessed by the question 'At any time in the past year, have you worked for payment?' RESULTS Interviews were conducted with 5571 subjects; 5314 (759 COPD and 4554 non-COPD) subjects underwent spirometry. Among the COPD subjects, 41.8% reported having paid work vs. 57.1% of non-COPD (P < 0.0001). The number of months with paid work was reduced in COPD patients (10.5 ± 0.17 vs. 10.9 ± 0.06, P < 0.05). The main factors associated with having paid work in COPD patients were male sex (OR 0.33, 95%CI 0.23-0.47), higher education level (OR 1.05, 95%CI 1.01-1.09) and younger age (OR 0.90, 95%CI 0.88-0.92). COPD was not a significant contributor to employment (OR 0.83, 95%CI 0.69-1.00, P = 0.054) in the entire population. CONCLUSIONS Although the proportion of persons with paid work is lower in COPD, having COPD appears not to have a significant impact on obtaining paid employment in the overall population of developing countries.
Collapse
Affiliation(s)
- M Montes de Oca
- Servicio de Neumonología, Hospital Universitario de Caracas, Facultad de Medicina, Universidad Central de Venezuela, Caracas, Venezuela.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Rafnar T, Vermeulen SH, Sulem P, Thorleifsson G, Aben KK, Witjes JA, Grotenhuis AJ, Verhaegh GW, Hulsbergen-van de Kaa CA, Besenbacher S, Gudbjartsson D, Stacey SN, Gudmundsson J, Johannsdottir H, Bjarnason H, Zanon C, Helgadottir H, Jonasson JG, Tryggvadottir L, Jonsson E, Geirsson G, Nikulasson S, Petursdottir V, Bishop DT, Chung-Sak S, Choudhury A, Elliott F, Barrett JH, Knowles MA, de Verdier PJ, Ryk C, Lindblom A, Rudnai P, Gurzau E, Koppova K, Vineis P, Polidoro S, Guarrera S, Sacerdote C, Panadero A, Sanz-Velez JI, Sanchez M, Valdivia G, Garcia-Prats MD, Hengstler JG, Selinski S, Gerullis H, Ovsiannikov D, Khezri A, Aminsharifi A, Malekzadeh M, van den Berg LH, Ophoff RA, Veldink JH, Zeegers MP, Kellen E, Fostinelli J, Andreoli D, Arici C, Porru S, Buntinx F, Ghaderi A, Golka K, Mayordomo JI, Matullo G, Kumar R, Steineck G, Kiltie AE, Kong A, Thorsteinsdottir U, Stefansson K, Kiemeney LA. European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene. Hum Mol Genet 2011; 20:4268-81. [PMID: 21750109 PMCID: PMC3188988 DOI: 10.1093/hmg/ddr303] [Citation(s) in RCA: 115] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2011] [Accepted: 07/07/2011] [Indexed: 11/14/2022] Open
Abstract
Three genome-wide association studies in Europe and the USA have reported eight urinary bladder cancer (UBC) susceptibility loci. Using extended case and control series and 1000 Genomes imputations of 5 340 737 single-nucleotide polymorphisms (SNPs), we searched for additional loci in the European GWAS. The discovery sample set consisted of 1631 cases and 3822 controls from the Netherlands and 603 cases and 37 781 controls from Iceland. For follow-up, we used 3790 cases and 7507 controls from 13 sample sets of European and Iranian ancestry. Based on the discovery analysis, we followed up signals in the urea transporter (UT) gene SLC14A. The strongest signal at this locus was represented by a SNP in intron 3, rs17674580, that reached genome-wide significance in the overall analysis of the discovery and follow-up groups: odds ratio = 1.17, P = 7.6 × 10(-11). SLC14A1 codes for UTs that define the Kidd blood group and are crucial for the maintenance of a constant urea concentration gradient in the renal medulla and, through this, the kidney's ability to concentrate urine. It is speculated that rs17674580, or other sequence variants in LD with it, indirectly modifies UBC risk by affecting urine production. If confirmed, this would support the 'urogenous contact hypothesis' that urine production and voiding frequency modify the risk of UBC.
Collapse
Affiliation(s)
| | - Sita H. Vermeulen
- Department of Epidemiology, Biostatistics and HTA
- Department of Genetics
| | - Patrick Sulem
- deCODE Genetics, Sturlugata 8, 101 Reykjavik, Iceland
| | | | - Katja K. Aben
- Department of Epidemiology, Biostatistics and HTA
- Integraal Kankercentrum Nederland, PO Box 1281, 6501 BG Nijmegen, The Netherlands
| | | | | | | | | | - Soren Besenbacher
- Bioinformatics Research Center, Aarhus University, 8000 Aarhus C, Denmark
| | | | | | | | | | | | - Carlo Zanon
- deCODE Genetics, Sturlugata 8, 101 Reykjavik, Iceland
| | | | - Jon Gunnlaugur Jonasson
- Icelandic Cancer Registry, Skogarhlid 8, 105 Reykjavik, Iceland
- Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland
| | - Laufey Tryggvadottir
- Icelandic Cancer Registry, Skogarhlid 8, 105 Reykjavik, Iceland
- Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland
| | | | | | - Sigfus Nikulasson
- Department of Pathology, Landspitali-University Hospital, 101 Reykjavik, Iceland
| | - Vigdis Petursdottir
- Department of Pathology, Landspitali-University Hospital, 101 Reykjavik, Iceland
| | | | - Sei Chung-Sak
- Section of Experimental Oncology, Leeds Institute of Molecular Medicine, St James's University Hospital, Beckett Street, LS9 7TF Leeds, UK
| | - Ananya Choudhury
- Christie Hospital National Health Service Foundation Trust, Wilmslow Road, M20 4BX Manchester, UK
| | | | | | - Margaret A. Knowles
- Section of Experimental Oncology, Leeds Institute of Molecular Medicine, St James's University Hospital, Beckett Street, LS9 7TF Leeds, UK
| | | | - Charlotta Ryk
- Urology Laboratory M1:02, Department of Molecular Medicine and Surgery and
| | - Annika Lindblom
- Department of Molecular Medicine and Surgery L1:00, Karolinska Institutet, 171 76 Stockholm, Sweden
| | - Peter Rudnai
- National Institute of Environmental Health, Josef Fodor Nation Center of Public Health, Nagyvarad ter 2, H-1450 Budapest, Hungary
| | - Eugene Gurzau
- Environmental Health Centre, Department of Health, Cetatti 23 A, 3400 Cluj-Napoca, Romania
| | - Kvetoslava Koppova
- State Health Institute, Cesta K. Nemocnici 1, SK-975 56 Banska Bystrica, Slovakia
| | - Paolo Vineis
- Human Genetics Foundation—HuGeF, Via Nizza 52, 10126 Torino, Italy
- Department of Epidemiology and Public Health, Imperial College, Norfolk Place W2 1PG, London, UK
| | - Silvia Polidoro
- Human Genetics Foundation—HuGeF, Via Nizza 52, 10126 Torino, Italy
| | | | - Carlotta Sacerdote
- Human Genetics Foundation—HuGeF, Via Nizza 52, 10126 Torino, Italy
- Centre for Cancer Epidemiology and Prevention (CPO Piemonte), Via Santena 19, 10126 Torino, Italy
| | - Angeles Panadero
- Ciudad de Coria Hospital, Avenida Cervantes 75, 10800 Coria, Spain
| | - José I. Sanz-Velez
- San Jorge University Hospital, Avenida Martínez de Velasco 36, 22004 Huesca, Spain
| | - Manuel Sanchez
- University of Zaragoza, Avenida San Juan Bosco 15, 50009 Zaragoza, Spain
| | - Gabriel Valdivia
- University of Zaragoza, Avenida San Juan Bosco 15, 50009 Zaragoza, Spain
| | | | - Jan G. Hengstler
- Leibniz Research Centre for Working Environment and Human Factors, Ardeystraße 67, D-44139 Dortmund, Germany
| | - Silvia Selinski
- Leibniz Research Centre for Working Environment and Human Factors, Ardeystraße 67, D-44139 Dortmund, Germany
| | - Holger Gerullis
- Department of Urology, Lukasklinik Neuss, Preussenstr. 64, D-41464 Neuss, Germany
| | - Daniel Ovsiannikov
- Department of Urology, St.-Josefs-Hospital Dortmund-Hörde, Wilhelm-Schmidt-Str. 4, D-44263 Dortmund, Germany
| | | | - Alireza Aminsharifi
- Department of Urology, Shiraz University of Medical Sciences, PO Box 71345–3119, Shiraz, Iran
| | | | | | - Roel A. Ophoff
- Department of Medical Genetics, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands
- UCLA Center for Neurobehavioral Genetics, 90095-1761 Los Angeles, CA, USA
| | | | - Maurice P. Zeegers
- Department of Complex Genetics, Cluster of Genetics and Cell Biology, Nutrition and Toxicology Research Institute and
- Unit of Genetic Epidemiology, Department of Public Health and Epidemiology, University of Birmingham, B15 2TT Birmingham, UK
| | - Eliane Kellen
- Leuven University Centre for Cancer Prevention, Kapucijnenvoer 33, B3000 Leuven, Belgium
| | - Jacopo Fostinelli
- Section of Occupational Medicine and Industrial Hygiene, Department of Experimental and Applied Medicine, University of Brescia, 1-25125 Brescia, Italy
| | - Daniele Andreoli
- Section of Occupational Medicine and Industrial Hygiene, Department of Experimental and Applied Medicine, University of Brescia, 1-25125 Brescia, Italy
| | - Cecilia Arici
- Section of Occupational Medicine and Industrial Hygiene, Department of Experimental and Applied Medicine, University of Brescia, 1-25125 Brescia, Italy
| | - Stefano Porru
- Section of Occupational Medicine and Industrial Hygiene, Department of Experimental and Applied Medicine, University of Brescia, 1-25125 Brescia, Italy
| | - Frank Buntinx
- Department of General Practice, Maastricht University, 6200 MD, Maastricht, The Netherlands
- Department of General Practice, Catholic University of Leuven, Kapucijnenvoer 33, B3000 Leuven, Belgium
| | | | - Klaus Golka
- Leibniz Research Centre for Working Environment and Human Factors, Ardeystraße 67, D-44139 Dortmund, Germany
| | - José I. Mayordomo
- University of Zaragoza, Avenida San Juan Bosco 15, 50009 Zaragoza, Spain
| | - Giuseppe Matullo
- Human Genetics Foundation—HuGeF, Via Nizza 52, 10126 Torino, Italy
- Department of Genetics, Biology and Biochemistry, University of Torino, Via Santena 19, 10126 Torino, Italy
| | - Rajiv Kumar
- Division of Molecular Genetic Epidemiology, German Cancer Research Centre, Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany
| | - Gunnar Steineck
- Division of Clinical Cancer Epidemiology, University of Gothenburg, Sahlgrenska University Hospital, SE - 413 45 Gothenburg, Sweden and
| | - Anne E. Kiltie
- Department of Oncology, Gray Institute for Radiation Oncology and Biology, University of Oxford, Old Road Campus Research Building, Off Roosevelt Drive, OX3 7DQ Oxford, UK
| | | | - Unnur Thorsteinsdottir
- deCODE Genetics, Sturlugata 8, 101 Reykjavik, Iceland
- Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland
| | - Kari Stefansson
- deCODE Genetics, Sturlugata 8, 101 Reykjavik, Iceland
- Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland
| | - Lambertus A. Kiemeney
- Department of Epidemiology, Biostatistics and HTA
- Department of Urology and
- Integraal Kankercentrum Nederland, PO Box 1281, 6501 BG Nijmegen, The Netherlands
| |
Collapse
|
13
|
Rothman N, Garcia-Closas M, Chatterjee N, Malats N, Wu X, Figueroa J, Real FX, Van Den Berg D, Matullo G, Baris D, Thun M, Kiemeney LA, Vineis P, De Vivo I, Albanes D, Purdue MP, Rafnar T, Hildebrandt MAT, Kiltie AE, Cussenot O, Golka K, Kumar R, Taylor JA, Mayordomo JI, Jacobs KB, Kogevinas M, Hutchinson A, Wang Z, Fu YP, Prokunina-Olsson L, Burdette L, Yeager M, Wheeler W, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Johnson A, Schwenn M, Karagas MR, Schned A, Andriole G, Grubb R, Black A, Jacobs EJ, Diver WR, Gapstur SM, Weinstein SJ, Virtamo J, Cortessis VK, Gago-Dominguez M, Pike MC, Stern MC, Yuan JM, Hunter D, McGrath M, Dinney CP, Czerniak B, Chen M, Yang H, Vermeulen SH, Aben KK, Witjes JA, Makkinje RR, Sulem P, Besenbacher S, Stefansson K, Riboli E, Brennan P, Panico S, Navarro C, Allen NE, Bueno-de-Mesquita HB, Trichopoulos D, Caporaso N, Landi MT, Canzian F, Ljungberg B, Tjonneland A, Clavel-Chapelon F, Bishop DT, Teo MTW, Knowles MA, Guarrera S, Polidoro S, Ricceri F, Sacerdote C, Allione A, Cancel-Tassin G, Selinski S, Hengstler JG, Dietrich H, Fletcher T, Rudnai P, Gurzau E, Koppova K, Bolick SCE, Godfrey A, Xu Z, Sanz-Velez JI, García-Prats MD, Sanchez M, Valdivia G, Porru S, Benhamou S, Hoover RN, Fraumeni JF, Silverman DT, Chanock SJ. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet 2010; 42:978-84. [PMID: 20972438 PMCID: PMC3049891 DOI: 10.1038/ng.687] [Citation(s) in RCA: 355] [Impact Index Per Article: 25.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2010] [Accepted: 08/19/2010] [Indexed: 12/12/2022]
Abstract
We conducted a multi-stage, genome-wide association study of bladder cancer with a primary scan of 591,637 SNPs in 3,532 affected individuals (cases) and 5,120 controls of European descent from five studies followed by a replication strategy, which included 8,382 cases and 48,275 controls from 16 studies. In a combined analysis, we identified three new regions associated with bladder cancer on chromosomes 22q13.1, 19q12 and 2q37.1: rs1014971, (P = 8 × 10⁻¹²) maps to a non-genic region of chromosome 22q13.1, rs8102137 (P = 2 × 10⁻¹¹) on 19q12 maps to CCNE1 and rs11892031 (P = 1 × 10⁻⁷) maps to the UGT1A cluster on 2q37.1. We confirmed four previously identified genome-wide associations on chromosomes 3q28, 4p16.3, 8q24.21 and 8q24.3, validated previous candidate associations for the GSTM1 deletion (P = 4 × 10⁻¹¹) and a tag SNP for NAT2 acetylation status (P = 4 × 10⁻¹¹), and found interactions with smoking in both regions. Our findings on common variants associated with bladder cancer risk should provide new insights into the mechanisms of carcinogenesis.
Collapse
Affiliation(s)
- Nathaniel Rothman
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
| | - Montserrat Garcia-Closas
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
| | - Nilanjan Chatterjee
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
| | - Nuria Malats
- Spanish National Cancer Research Centre, Madrid, Spain
| | - Xifeng Wu
- Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
| | - Jonine Figueroa
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
| | - Francisco X Real
- Spanish National Cancer Research Centre, Madrid, Spain
- Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain
| | - David Van Den Berg
- Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA
| | - Giuseppe Matullo
- Department of Genetics, Biology and Biochemistry, University of Torino, Torino, Italy
- Human Genetics Foundation (HuGeF), Torino, Italy
| | - Dalsu Baris
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
| | - Michael Thun
- Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, USA
| | - Lambertus A Kiemeney
- Department of Epidemiology, Biostatistics and Health Technology Assessment, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
- Comprehensive Cancer Center East, Nijmegen, The Netherlands
- Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
| | - Paolo Vineis
- Human Genetics Foundation (HuGeF), Torino, Italy
- Imperial College London, London, UK
| | - Immaculata De Vivo
- Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, USA
| | - Demetrius Albanes
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
| | - Mark P Purdue
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
| | | | - Michelle A T Hildebrandt
- Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
| | - Anne E Kiltie
- Gray Institute for Radiation Oncology and Biology, University of Oxford, Oxford, UK
| | - Olivier Cussenot
- Department of Urology, Assistance Publique-Hôpitaux de Paris, Tenon Hospital, Paris, France
- Centre de Recherche sur les Pathologies Prostatiques, Paris, France
| | - Klaus Golka
- Leibniz Research Centre for Working Environment and Human Factors, Dortmund, Germany
| | - Rajiv Kumar
- Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany
| | - Jack A Taylor
- National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA
| | | | - Kevin B Jacobs
- Core Genotype Facility, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland, USA
| | - Manolis Kogevinas
- Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain
- Municipal Institute of Medical Research, Barcelona, Spain
- CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain
- National School of Public Health, Athens, Greece
| | - Amy Hutchinson
- Core Genotype Facility, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland, USA
| | - Zhaoming Wang
- Core Genotype Facility, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland, USA
| | - Yi-Ping Fu
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
| | - Ludmila Prokunina-Olsson
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
| | - Laurie Burdette
- Core Genotype Facility, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland, USA
| | - Meredith Yeager
- Core Genotype Facility, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland, USA
| | - William Wheeler
- Information Management Services, Inc., Rockville, Maryland, USA
| | - Adonina Tardón
- CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain
- Instituto Universitario de Oncología, Universidad de Oviedo, Oviedo, Spain
| | | | | | - Reina García-Closas
- Unidad de Investigación, Hospital Universitario de Canarias, La Laguna, Spain
| | - Josep Lloreta
- Hospital del Mar-IMIM, Univesitat Pompeu Fabra, Barcelona, Spain
| | | | | | | | - Alan Schned
- Dartmouth Medical School, Hanover, New Hampshire, USA
| | - Gerald Andriole
- Department of Urology, Washington University School of Medicine, St. Louis, Missouri, USA
| | - Robert Grubb
- Department of Urology, Washington University School of Medicine, St. Louis, Missouri, USA
| | - Amanda Black
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
| | - Eric J Jacobs
- Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, USA
| | - W Ryan Diver
- Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, USA
| | - Susan M Gapstur
- Epidemiology Research Program, American Cancer Society, Atlanta, Georgia, USA
| | - Stephanie J Weinstein
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
| | - Jarmo Virtamo
- National Institute for Health and Welfare, Helsinki, Finland
| | - Victoria K Cortessis
- Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain
| | - Manuela Gago-Dominguez
- Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain
| | - Malcolm C Pike
- Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain
- Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, USA
| | - Mariana C Stern
- Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain
| | - Jian-Min Yuan
- Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA
| | - David Hunter
- Department of Epidemiology, Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA
| | - Monica McGrath
- Department of Epidemiology, Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA
| | - Colin P Dinney
- Department of Urology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
| | - Bogdan Czerniak
- Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
| | - Meng Chen
- Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
| | - Hushan Yang
- Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
| | - Sita H Vermeulen
- Department of Epidemiology, Biostatistics and Health Technology Assessment, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
- Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
| | - Katja K Aben
- Department of Epidemiology, Biostatistics and Health Technology Assessment, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
- Comprehensive Cancer Center East, Nijmegen, The Netherlands
| | - J Alfred Witjes
- Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
| | - Remco R Makkinje
- Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
| | | | | | - Kari Stefansson
- deCODE Genetics, Reykjavik, Iceland
- Faculty of Medicine, University of Iceland, Reykjavik, Iceland
| | | | - Paul Brennan
- International Agency for Research on Cancer, Lyon, France
| | - Salvatore Panico
- Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy
| | - Carmen Navarro
- CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain
- Department of Epidemiology, Murcia Regional Health Council, Murcia, Spain
| | - Naomi E Allen
- Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine University of Oxford, Oxford, UK
| | | | - Dimitrios Trichopoulos
- Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA
- Bureau of Epidemiologic Research, Academy of Athens, Greece
| | - Neil Caporaso
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
| | - Maria Teresa Landi
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
| | - Federico Canzian
- Genomic Epidemiology Group, German Cancer Research Center, Heidelberg, Germany
| | - Borje Ljungberg
- Department of Surgical and Perioperative Sciences, University of Umea, Umea, Sweden
| | - Anne Tjonneland
- Danish Cancer Society, Institute of Cancer Epidemiology, Copenhagen, Denmark
| | - Francoise Clavel-Chapelon
- Centre for Research in Epidemiology and Population Health, Institute Gustave-Roussy, Paris South University, Villejuif, France
| | - David T Bishop
- Leeds Institute of Molecular Medicine, St James’s University Hospital, University of Leeds, Leeds, UK
| | - Mark T W Teo
- Leeds Institute of Molecular Medicine, St James’s University Hospital, University of Leeds, Leeds, UK
| | - Margaret A Knowles
- Leeds Institute of Molecular Medicine, St James’s University Hospital, University of Leeds, Leeds, UK
| | | | | | - Fulvio Ricceri
- Department of Genetics, Biology and Biochemistry, University of Torino, Torino, Italy
- Human Genetics Foundation (HuGeF), Torino, Italy
| | - Carlotta Sacerdote
- Human Genetics Foundation (HuGeF), Torino, Italy
- Unit of Cancer Epidemiology, University of Torino, Torino, Italy
| | | | | | - Silvia Selinski
- Leibniz Research Centre for Working Environment and Human Factors, Dortmund, Germany
| | - Jan G Hengstler
- Leibniz Research Centre for Working Environment and Human Factors, Dortmund, Germany
| | - Holger Dietrich
- Department of Urology, Paul Gerhardt Foundation, Wittenberg, Germany
| | - Tony Fletcher
- Institute of Hygiene and Tropical Medicine, London, UK
| | - Peter Rudnai
- National Institute of Environmental Health, Budapest, Hungary
| | - Eugen Gurzau
- Babes Bolyai University, Environmental Health Center, Cluj-Napoca, Romania
| | | | - Sophia C E Bolick
- National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA
| | - Ashley Godfrey
- National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA
| | - Zongli Xu
- National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA
| | | | | | | | | | - Stefano Porru
- Department of Experimental and Applied Medicine, Section of Occupational Medicine and Industrial Hygiene, University of Brescia, Italy
| | - Simone Benhamou
- Institut national de la santé et de la recherche médicale, U946, Fondation Jean Dausset-CEPH, Paris, France
- Centre national de la recherche scientifique, UMR8200, Institut Gustave-Roussy, Villejuif, France
| | - Robert N Hoover
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
| | - Joseph F Fraumeni
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
| | - Debra T Silverman
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
| | - Stephen J Chanock
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA
| |
Collapse
|
14
|
Kiemeney LA, Sulem P, Besenbacher S, Vermeulen SH, Sigurdsson A, Thorleifsson G, Gudbjartsson DF, Stacey SN, Gudmundsson J, Zanon C, Kostic J, Masson G, Bjarnason H, Palsson ST, Skarphedinsson OB, Gudjonsson SA, Witjes JA, Grotenhuis AJ, Verhaegh GW, Bishop DT, Sak SC, Choudhury A, Elliott F, Barrett JH, Hurst CD, de Verdier PJ, Ryk C, Rudnai P, Gurzau E, Koppova K, Vineis P, Polidoro S, Guarrera S, Sacerdote C, Campagna M, Placidi D, Arici C, Zeegers MP, Kellen E, Gutierrez BS, Sanz-Velez JI, Sanchez-Zalabardo M, Valdivia G, Garcia-Prats MD, Hengstler JG, Blaszkewicz M, Dietrich H, Ophoff RA, van den Berg LH, Alexiusdottir K, Kristjansson K, Geirsson G, Nikulasson S, Petursdottir V, Kong A, Thorgeirsson T, Mungan NA, Lindblom A, van Es MA, Porru S, Buntinx F, Golka K, Mayordomo JI, Kumar R, Matullo G, Steineck G, Kiltie AE, Aben KKH, Jonsson E, Thorsteinsdottir U, Knowles MA, Rafnar T, Stefansson K. A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer. Nat Genet 2010; 42:415-9. [PMID: 20348956 PMCID: PMC2923020 DOI: 10.1038/ng.558] [Citation(s) in RCA: 144] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2009] [Accepted: 03/03/2010] [Indexed: 12/17/2022]
Abstract
Previously, we reported germline DNA variants associated with risk of urinary bladder cancer (UBC) in Dutch and Icelandic subjects. Here we expanded the Icelandic sample set and tested the top 20 markers from the combined analysis in several European case-control sample sets, with a total of 4,739 cases and 45,549 controls. The T allele of rs798766 on 4p16.3 was found to associate with UBC (odds ratio = 1.24, P = 9.9 x 10(-12)). rs798766 is located in an intron of TACC3, 70 kb from FGFR3, which often harbors activating somatic mutations in low-grade, noninvasive UBC. Notably, rs798766[T] shows stronger association with low-grade and low-stage UBC than with more aggressive forms of the disease and is associated with higher risk of recurrence in low-grade stage Ta tumors. The frequency of rs798766[T] is higher in Ta tumors that carry an activating mutation in FGFR3 than in Ta tumors with wild-type FGFR3. Our results show a link between germline variants, somatic mutations of FGFR3 and risk of UBC.
Collapse
Affiliation(s)
- Lambertus A Kiemeney
- Department of Epidemiology, Biostatistics and Health Technology Assessment, Nijmegen, The Netherlands.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Lopez Varela MV, Montes de Oca M, Halbert RJ, Muino A, Perez-Padilla R, Talamo C, Jardim JRB, Valdivia G, Pertuze J, Moreno D, Menezes AMB. Sex-related differences in COPD in five Latin American cities: the PLATINO study. Eur Respir J 2010; 36:1034-41. [DOI: 10.1183/09031936.00165409] [Citation(s) in RCA: 85] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
16
|
Menezes AMB, Perez-Padilla R, Hallal PC, Jardim JR, Muiño A, Lopez MV, Valdivia G, Pertuze J, Montes de Oca M, Tálamo C. Worldwide burden of COPD in high- and low-income countries. Part II. Burden of chronic obstructive lung disease in Latin America: the PLATINO study. Int J Tuberc Lung Dis 2008; 12:709-712. [PMID: 18544192] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/26/2023] Open
Abstract
SETTING Five Latin American cities: São Paulo, Brazil; Mexico City, Mexico; Montevideo, Uruguay; Santiago, Chile; Caracas, Venezuela. OBJECTIVE To describe the burden of chronic obstructive pulmonary disease (COPD) in Latin America. DESIGN This is a multicentre study. Post-bronchodilator spirometry was used and the main outcome measure was FEV(1)/FVC < 0.7 (fixed ratio criterion). Global Obstructive Lung Disease (GOLD) stages were also analysed. RESULTS The combined population aged > or =40 years in the five countries included in the study was approximately 85.3 million. Of these, it was estimated that 12.2 million have airflow obstruction, which corresponds to our prevalence estimate of 14.3%. The proportion of subjects in Stages II-IV of the GOLD classification was 5.6%. Risk factors presenting the highest aetiological fractions for COPD were age, current smoking, indoor exposure to coal and exposure to dust in the workplace. Smoking, the modifiable factor with the strongest aetiological fraction for COPD, affects 29.2% of adults aged > or =40 years in these cities, corresponding to approximately 25 million smokers in this age group. CONCLUSION Prevention of smoking and exposure to pollutants, such as coal and dust, are the interventions most likely to succeed against COPD in Latin America. The information obtained by a collaborative study has been vast and encouraging for other similar studies.
Collapse
Affiliation(s)
- A M B Menezes
- Post-graduate Programme in Epidemiology, Federal University of Pelotas, Pelotas, Brazil.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Menezes AMB, Hallal PC, Perez-Padilla R, Jardim JRB, Muiño A, Lopez MV, Valdivia G, Montes de Oca M, Talamo C, Pertuze J, Victora CG. Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America. Eur Respir J 2007; 30:1180-5. [PMID: 17804445 DOI: 10.1183/09031936.00083507] [Citation(s) in RCA: 154] [Impact Index Per Article: 9.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
The aim of the present study was to evaluate the association between history of tuberculosis and airflow obstruction. A population-based, multicentre study was carried out and included 5,571 subjects aged > or =40 yrs living in one of five Latin American metropolitan areas: Sao Paulo (Brazil); Montevideo (Uruguay); Mexico City (Mexico); Santiago (Chile); and Caracas (Venezuela). Subjects performed pre- and post-bronchodilator spirometry and were asked whether they had ever been diagnosed with tuberculosis by a physician. The overall prevalence of airflow obstruction (forced expiratory volume in one second/forced vital capacity post-bronchodilator <0.7) was 30.7% among those with a history of tuberculosis, compared with 13.9% among those without a history. Males with a medical history of tuberculosis were 4.1 times more likely to present airflow obstruction than those without such a diagnosis. This remained unchanged after adjustment for confounding by age, sex, schooling, ethnicity, smoking, exposure to dust and smoke, respiratory morbidity in childhood and current morbidity. Among females, the unadjusted and adjusted odds ratios were 2.3 and 1.7, respectively. In conclusion, history of tuberculosis is associated with airflow obstruction in Latin American middle-aged and older adults.
Collapse
|
18
|
Valdivia G. [Bronchial asthma and atopic diseases as an emerging problem in public health: new etiological hypothesis. The experience of developed societies]. Rev Med Chil 2000; 128:339-46. [PMID: 10962878] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/17/2023]
Abstract
Developed countries report increasing trends in the prevalence of asthma and atopic diseases over the last 40 years. This change cannot be attributed to artefactual effects. Emerging from these information, new approaches have been generated to explore these novel findings. Among the most important new factors to be explored, scientific research is pointing out to variables related with physical environment, socio-economic and genetic background, anthropometry at birth, nutritional status, diet, exercise and hormonal profile. Changes in the epidemiology of asthma and atopic conditions in developed countries were also preceded by increases in the prevalence of chronic diseases and their risk factors. Chile does not have information about time trends on these diseases, but several studies are reporting a high prevalence of asthma among adults. Conversely, results from the collaborative ISAAC study carried out in children, have shown a relative low prevalence of asthma in Chilean children. An increasing trend in chronic diseases and their risk factors has been reported in Chile, suggesting an epidemiological pattern similar to that experienced by industrialised countries, when the prevalence of asthma and atopic began to increase. This article review current information about etiological research emphasising the need to develop local research on asthma and atopic diseases taking into account our epidemiological situation.
Collapse
Affiliation(s)
- G Valdivia
- Departamento de Salud Pública, Pontificia Universidad Católica de Chile.
| |
Collapse
|
19
|
Alba-Hurtado F, Díaz-Otero F, Valdivia G, Reyes R, Tsutsumi V, Acosta G. Cellular immune response of intracecally inoculated Mongolian gerbils with Entamoeba histolytica trophozoites. Rev Latinoam Microbiol 1999; 41:205-10. [PMID: 10932762] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/17/2023]
Abstract
We analyzed the local and systemic cellular immune response in mongolian gerbils inoculated with Entamoeba histolytica. Two groups were intracecally inoculated with E. histolytica trophozoites and two groups were used as controls. A inoculated groups and a control groups were sacrificed on days 10 and 30 post inoculation (p.i), the spleen and mesenteric lymph nodes (MLNs) lymphocytes (Ly) were isolated and incubated in vitro with 2 different amebic antigens. The proliferative Ly response of inoculated groups was greater than the Ly mitogenic response seen in control groups, at day 10 p.i. as well as day 30 p.i. (alpha = 0.05). Ly response of MLNs was greater in comparison to those of the spleen (alpha = 0.05). In other four groups, intradermal reactions with a antigen were used to demonstrated delayed hypersensitivity in gerbils after being inoculated with E. histolytica trophozoites. The percentage of volume increase of the plantar pad swelling were measured. Groups inoculated presented greater increases (alpha = 0.05) than groups controls. The evidence presented herein demonstrates that the presence of E. histolytica trophozoites in cecum induced a local and systemic cellular immune response.
Collapse
Affiliation(s)
- F Alba-Hurtado
- Departamento de Ciencias Biológicas, Facultad de Estudios Superiores, Cuautitlán, Universidad Nacional Autónoma de México
| | | | | | | | | | | |
Collapse
|
20
|
Valdivia G, Bastías G. [Gastric cancer and cerebrovascular diseases. A natural history with common elements? Analysis of the salt theory in Chile (1955-1994)]. Rev Med Chil 1999; 127:1041-8. [PMID: 10752266] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/16/2023]
Abstract
BACKGROUND In the last forty years, a sustained reduction in the gastric cancer and cerebrovascular disease mortality has been recorded. Joossens has postulated that sodium intake has an influence in the natural history of both diseases. AIM To analyze the mortality caused by both diseases in Chile. MATERIAL AND METHODS The mortality of people aged 35 to 64 years old, due to gastric cancer and cerebrovascular diseases in the period 1955-1994, was analyzed. An analysis according to regions, using temporal series and correlation techniques was performed. RESULTS In the studied period, the mortality due to gastric cancer decreased by 71.6% in men and by 79.5% in women. Mortality due to cerebrovascular diseases decreased by 56.9% in men and by 63.9% in women. There was a correlation coefficient of +0.91 between the mortality due to both diseases. Cerebrovascular disease mortality appears as a predictor of gastric cancer mortality in temporal series analysis. CONCLUSIONS Joossens theories are supported by the present data. Prospective studies should be designed to confirm the hypothesis.
Collapse
Affiliation(s)
- G Valdivia
- Departamento de Salud Pública, Facultad de Medicina, Pontificia Universidad Católica de Chile.
| | | |
Collapse
|
21
|
Pertuzé J, Valdivia G, Barros M, Añazco J, Olaeta I. [Respiratory symptoms and cough reflex in populations exposed to different degrees of environmental pollution]. Rev Med Chil 1997; 125:1145-55. [PMID: 9609032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
BACKGROUND Santiago is a city with a high degree of environmental pollution caused by particulate matter and ozone, producing adverse effects in the respiratory system. AIM To compare respiratory symptoms and cough reflex in adults from Santiago and from a rural area with low levels of environmental pollution. SUBJECTS AND METHODS One hundred twenty six non-smoker adults from Santiago and 116 from a rural area with low levels of pollution answered a respiratory symptom questionnaire. Of these 101 subjects from Santiago and 116 from the rural area inhaled doubling concentrations of capsaicin from 0.5 to 500 microM or until five coughs were elicited. The lowest concentration eliciting 2 or more coughs (CD2) or 5 or more coughs (CD5) was recorded. Levels of environmental particulate matter were also recorded in both locations. RESULTS Levels of particulate matter were 102 +/- 41 and 64 +/- 24 micrograms/m3 in Santiago and the rural area respectively. People from Santiago had higher rates of throat clearing, cough and phlegm. CD2 geometric mean and confidence limits in Santiago and the rural area were 6.9 (5.2-7.4) and 2.8 (2.7-2.9) respectively (p < 0.001). No differences in CD5 were observed between both locations. Multivariate analysis disclosed the variable location (city) as the only independent predictor of respiratory symptoms. CONCLUSIONS The increased CD2 found in Santiago suggests that the higher rates of respiratory symptoms related to air pollution can be associated to a decreased sensitivity of the cough reflex.
Collapse
Affiliation(s)
- J Pertuzé
- Departamento de Enfermedades Respiratorias, Facultad de Medicina, P Universidad Católica de Chile, Santiago, Chile
| | | | | | | | | |
Collapse
|
22
|
Valdivia G, Bastías G, Berríos X. 1.P.353 Trends in cardiovascular mortality in a developing country. Atherosclerosis 1997. [DOI: 10.1016/s0021-9150(97)88532-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
23
|
Valenzuela R, Valdivia G. 2-36-08 Underestimation of the importance of neurologic diseases in mortality statistics. J Neurol Sci 1997. [DOI: 10.1016/s0022-510x(97)85460-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
24
|
Hochberg F, Miller G, Valenzuela R, McNelis S, Crump KS, Covington T, Valdivia G, Hochberg B, Trustman JW. Late motor deficits of Chilean manganese miners: a blinded control study. Neurology 1996; 47:788-95. [PMID: 8797481 DOI: 10.1212/wnl.47.3.788] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023] Open
Abstract
High-level chronic manganese (Mn) exposure produces dystonic rigidity and proximal tremor. The late effects of asymptomatic exposure are uncertain. To evaluate hand movements of asymptomatic Chilean miners, we utilized a manual tremormeter (EAP) and a digitizing tablet (MOVEMAP). In Andacollo, Chile, we examined 59 individuals aged > 50 years (mean age, 64.4 years). Twenty-seven exposed miners had heavy Mn dust exposure in Mn mines for more than 5 years (mean duration, 20.25 years), ending at least 5 years previously. Thirty-two control miners had never worked in Mn mines or had short-term Mn employment. Tests of resting tremor (EAP Tremormeter, MOVEMAP Steady paradigm), action tremor (MOVEMAP Square paradigm), and repetitive hand movements (EAP Tapping Test and Orthokinesimeter) differentiated performance of exposed miners from that of controls. Chronic asymptomatic Mn exposure results in detectable late-life abnormalities of movement.
Collapse
Affiliation(s)
- F Hochberg
- Massachusetts General Hospital, Boston, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Valdivia G, Giaconi J, Arteaga E, Pumarino H, Gajardo H, Villarroel L. [Hip fracture: a case-control study in the metropolitan region I]. Rev Med Chil 1996; 124:189-97. [PMID: 9213887] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
BACKGROUND Hip fracture is a preventable cause of disability among elderly people AIM To study factors associated to hip fractures in Chile. PATIENTS AND METHODS Patients admitted to seven public hospitals in Chile, with hip fracture not due to major accidents, were considered as cases. To each, at least one age and sex matched hospitalized control, without or neoplastic diseases, was assigned. All patients were subjected to an inquiry, using an instrument devised by the WHO. RESULTS Two hundred sixty eight cases and 501 controls were studied. Cases and controls has similar educational and labor histories. The right hip was fractures in 47% of cases and the left in the rest. Compared with controls, cases had a higher body mass index, loss of height during life, rate of hysterectomy, incidence of smoking and a lower consumption of diary products. Cases had higher risk of falls inside their homes and controls outside. CONCLUSIONS The obtained information may contribute to the development of preventive measures and reduce the public health impact of hip fracture.
Collapse
Affiliation(s)
- G Valdivia
- Departamento de Salud Pública, Universidad Católica de Chile, Santiago de Chile
| | | | | | | | | | | |
Collapse
|
26
|
Arteaga E, Campusano C, Rodríguez JA, Cervilla V, López JM, Valdivia G. [Frequency of lumbar spine osteopenia in an asymptomatic postmenopausal Chilean population]. Rev Med Chil 1994; 122:372-7. [PMID: 7809531] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
The aim of this study was to assess lumbar spine bone density in a group of chilean postmenopausal females and to estimate the frequency of vertebral osteopenia in the national urban female population. A clinical assessment and lumbar spine bone density measurement were performed to 171 healthy women over 40 years of age and not receiving medications that modify bone turnover. Calcium ingestion was recalled in 77 of these. Fifty women (29.2%) had osteopenia, defined as a bone density of less than 0.92 g/cm2. Extrapolating this figure to the national urban population, an osteopenia frequency of 21.7% was estimated. Body mass index was 25.5 +/- 3.8 and 57% of the sample was overweight. Calcium ingestion was 740.3 +/- 331.7. These two parameters did not correlative with bone density. Women with osteopenia were older and had a longer postmenopausal lapse than those with normal bone density. The completion of further clinical an epidemiological studies is recommended to know the real magnitude of osteoporosis in Chile.
Collapse
Affiliation(s)
- E Arteaga
- Departmento de Endocrinología, Facultad de Medicina, Santiago de Chile Universidad Católica de Chile
| | | | | | | | | | | |
Collapse
|
27
|
Horwitz N, Muñoz MG, Ochoa JA, Ringeling I, Sarué E, Valdivia G. [Evaluation study of a training program: primary care workshops]. Educ Med Salud 1994; 28:234-48. [PMID: 7925084] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Affiliation(s)
- N Horwitz
- Facultad de Medicina, Universidad de Chile
| | | | | | | | | | | |
Collapse
|
28
|
Navarro R, Yupanqui M, Geng J, Valdivia G, Girón M, Rojas M, Rodríguez E, Beletti A. Development of a program of behavior modification directed to the rehabilitation of drug-dependent patients: treatment and follow-up of 223 cases. Int J Addict 1992; 27:391-408. [PMID: 1563892 DOI: 10.3109/10826089209068749] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
The study reports treatment and follow-up of compulsive drug-consuming patients (mainly of coca paste). The program used was based on a behavioral cognitive and instructional model. The traditional functional analysis was modified to include the therapeutical work in seven behavioral areas: (1) drug use; (2) behavior during free time; (3) behavior at work; (4) social behavior; (5) self- and environmental management behaviors; (6) problem solving and decision-making behaviors; (7) recognition, evaluation, and modification of irrational beliefs. For each area objectives, therapeutical procedures, control and evaluation methods, and termination criteria were determined. Patients engaged in a multiple activity program and received individual and group therapy. Out of 223 male patients, 130 were discharged (that is, they fulfilled all the conditions stated by the program) and 93 patients abandoned treatment. For evaluation purposes a test was used to determine the accomplishment of the behavioral objectives. Follow-up interviews after 6 to 72 months showed that although 24 patients relapsed to drug use, 106 (81.48%) of the patients who had finished the program restrained from using drugs and obtained high scores in all seven behavioral areas.
Collapse
Affiliation(s)
- R Navarro
- Drug Dependency Rehabilitation Center, Naña, Peru
| | | | | | | | | | | | | | | |
Collapse
|
29
|
Chianale J, Valdivia G, del Pino G, Nervi F. [Gallbladder cancer mortality in Chile and its relation to cholecystectomy rates. An analysis of the last decade]. Rev Med Chil 1990; 118:1284-8. [PMID: 2152657] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Extrahepatic biliary tract cancer (mainly gallbladder cancer) mortality rates have increased from 7.84 x 100.000 to 9.6 x 100.000 in Chile during the last decade. The most significant risk factor for gallbladder cancer is gallstone disease. However, no apparent changes in the prevalence of gallstone disease has occurred during this period. In contrast, cholecystectomy rates have consistently decreased during the decade. The aim of this study was to correlate extrahepatic biliary tract cancer mortality and cholecystectomy rates of previous years during the last decade in our country. The best correlation coefficient between both variables was obtained when mortality was correlated with cholecystectomy rates two years prior to the mortality rate (r = -0.92). This finding is consistent with the hypothesis that changes in the number of cholecystectomies performed in a specific geographic area would reciprocally change gallbladder cancer mortality rate. It was estimated that increasing cholecystectomies by 12,500 per year would decrease at mortality rate from this cancer by approximately 1.0 x 100.000 two years in Chile.
Collapse
Affiliation(s)
- J Chianale
- Departamento de Gastroenterología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago
| | | | | | | |
Collapse
|